| The immunogenetics of psoriasis: a comprehensive review JL Harden, JG Krueger, AM Bowcock Journal of autoimmunity 64, 66-73, 2015 | 672 | 2015 |
| Indoleamine 2, 3-dioxygenase and dendritic cell tolerogenicity JL Harden, NK Egilmez Immunological investigations 41 (6-7), 738-764, 2012 | 182 | 2012 |
| Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches M Moyle, F Cevikbas, JL Harden, E Guttman‐Yassky Experimental dermatology 28 (7), 756-768, 2019 | 151 | 2019 |
| Tolerogenic phenotype of IFN-γ–induced IDO+ dendritic cells is maintained via an autocrine IDO–kynurenine/AhR–IDO loop Q Li, JL Harden, CD Anderson, NK Egilmez The Journal of Immunology 197 (3), 962-970, 2016 | 134 | 2016 |
| The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases JL Harden, SM Lewis, SR Lish, M Suárez-Fariñas, D Gareau, T Lentini, ... Journal of Allergy and Clinical Immunology 137 (6), 1830-1840, 2016 | 125 | 2016 |
| Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis JL Harden, LM Johnson-Huang, MF Chamian, E Lee, T Pearce, ... Journal of Allergy and Clinical Immunology 135 (2), 553-556. e3, 2015 | 125 | 2015 |
| TREM-1 as a potential therapeutic target in psoriasis LA Hyder, J Gonzalez, JL Harden, LM Johnson-Huang, LC Zaba, ... Journal of Investigative Dermatology 133 (7), 1742-1751, 2013 | 68 | 2013 |
| CARD14 expression in dermal endothelial cells in psoriasis JL Harden, SM Lewis, KC Pierson, M Suárez-Fariñas, T Lentini, ... PloS one 9 (11), e111255, 2014 | 66 | 2014 |
| Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity MO Kilinc, T Gu, JL Harden, LP Virtuoso, NK Egilmez The Journal of Immunology 182 (7), 4217-4225, 2009 | 63 | 2009 |
| Deep sequencing of the T-cell receptor repertoire demonstrates polyclonal T-cell infiltrates in psoriasis JL Harden, D Hamm, N Gulati, MA Lowes, JG Krueger F1000Research 4, 2015 | 57 | 2015 |
| Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β P Aubert, M Suárez-Fariñas, H Mitsui, LM Johnson-Huang, JL Harden, ... PloS one 7 (11), e49408, 2012 | 46 | 2012 |
| Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12–driven antitumor T cell immunity JL Harden, T Gu, MO Kilinc, RB Rowswell-Turner, LP Virtuoso, ... The Journal of Immunology 187 (1), 126-132, 2011 | 35 | 2011 |
| Characterization of iNOS+ Neutrophil-like ring cell in tumor-bearing mice LP Virtuoso, JL Harden, P Sotomayor, WJ Sigurdson, F Yoshimura, ... Journal of Translational Medicine 10, 1-12, 2012 | 21 | 2012 |
| Nitric oxide short-circuits interleukin-12-mediated tumor regression NK Egilmez, JL Harden, LP Virtuoso, RA Schwendener, MO Kilinc Cancer Immunology, Immunotherapy 60, 839-845, 2011 | 21 | 2011 |
| Chemoimmunotherapy as long-term maintenance therapy for cancer NK Egilmez, JL Harden, RB Rowswell-Turner Oncoimmunology 1 (4), 563-565, 2012 | 17 | 2012 |
| Paired transcriptomic and proteomic analysis implicates IL-1β in the pathogenesis of papulopustular rosacea explants JL Harden, YH Shih, J Xu, R Li, D Rajendran, H Hofland, ALS Chang Journal of Investigative Dermatology 141 (4), 800-809, 2021 | 12 | 2021 |
| Chronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counter-regulation RB Rowswell-Turner, JL Harden, RE Nair, T Gu, MO Kilinc, NK Egilmez The Journal of Immunology 187 (8), 4109-4118, 2011 | 9 | 2011 |
| Chemoimmunotherapy as long-term maintenance therapy for cancer. Oncoimmunology 2012; 1: 563-5; PMID: 22754788 NK Egilmez, JL Harden, RB Rowswell-Turner | 3 | |
| LB1144 Quantitative analysis of differentially expressed proteins in papulopustular rosacea JL Harden, Y Shih, D Rajendran, H Hofland, A Chang Journal of Investigative Dermatology 139 (9), B25, 2019 | 1 | 2019 |
| IRAK4 Inhibitors and Topical Uses Thereof JL Harden, D Imbert US Patent App. 18/007,950, 2023 | | 2023 |
